Tamsulosin for Reproducible Cell Assays
2026-09-09
This scenario-driven guide explains how Tamsulosin (SKU C6445) can support controlled α1A-adrenergic receptor experiments without confusing receptor pharmacology with nonspecific cytotoxicity. It covers assay design, solvent compatibility, protocol optimization, data interpretation, and practical vendor-selection criteria for biomedical laboratories.
Anlotinib and VEGFR2-Driven Tumor Angiogenesis
2026-09-08
The reference study established anlotinib as a highly potent, orally active, and comparatively selective VEGFR2 inhibitor whose antitumor activity was primarily linked to suppression of tumor angiogenesis. Its integrated biochemical, endothelial, ex vivo vascular, and xenograft experiments provide a useful framework for interpreting migration, tube formation, vascular-density, and tumor-growth endpoints.
Silybin A: A Translational Strategy for Liver Research
2026-09-08
Silybin A can serve as a chemically defined tool for connecting redox, inflammatory, autophagy, and metastatic phenotypes in liver research. This thought-leadership guide explains how to move beyond generic Silymarin claims by controlling identity, solubility, assay design, and mechanistic validation.
MnTBAP Chloride in Chronic Stress Models
2026-09-07
MnTBAP Chloride helps researchers test how mitochondrial superoxide connects oxidative stress, inflammation, and behavior. This evidence-focused guide translates chronic stress findings into practical assay design, controls, and interpretation decisions.
Trigeminal Allodynia via the CGRP/SP–Piezo2 Axis
2026-09-05
Liao et al. connect chronic trigeminal root entry zone compression with a Ca2+-regulated CGRP/SP–Piezo2 feedback loop that links neuroinflammation to mechanical allodynia. Their combination of behavioral, molecular, knockdown, and in vitro signaling experiments identifies the trigeminal ganglion–Merkel cell axis as a mechanistic framework for studying trigeminal neuralgia.
Dimetridazole Restores Cefotaxime Activity in MDR E. coli
2026-09-05
A 2025 Scientific Reports study shows that Dimetridazole can potentiate cefotaxime against a multidrug-resistant E. coli strain, with the combination linked to altered membrane permeability, integrity, and fatty acid biosynthesis. Its checkerboard, microscopy, lipid-composition, gene-expression, and Galleria mellonella experiments provide a mechanistic framework for antibiotic-rescue research while leaving clinical translation unresolved.
PBS (Phosphate-Buffered Saline): Lab Guide
2026-09-04
PBS (Phosphate-Buffered Saline), SKU K2818, provides a sterile, ready-to-use isotonic buffer for cell washing, reagent dilution, and selected in vitro protein-assay workflows. It is a research-use buffer rather than a culture medium and should not be used for diagnostic, clinical, medical, or in vivo applications.
PHF2 Links Neuroinflammation to Alzheimer’s Disease
2026-09-04
A 2025 Molecular Psychiatry study identifies the histone demethylase PHF2 as an epigenetic regulator connecting inflammatory gene expression with synaptic and cognitive deficits in Alzheimer’s disease. By combining human tissue, patient-derived neurons, transcriptomic prioritization, chromatin profiling, and in vivo knockdown, the work provides a mechanistic framework for evaluating PHF2 as a potential intervention point.
METTL17, Mitochondrial Translation and CRC Ferroptosis
2026-09-03
The reference study identifies METTL17 as a mitochondrial RNA methylation regulator that links mitochondrial translation with ferroptosis resistance and colorectal cancer progression. Its combination of molecular, cellular, and in vivo experiments supports METTL17 as a potential vulnerability for ferroptosis-based colorectal cancer research, while also defining important limits for therapeutic interpretation.
BH3 Mimetics Clear Senescent Breast Cancer Cells
2026-09-03
The reference study shows that chemotherapy-induced senescent breast cancer cells can remain viable and promote relapse, particularly in TP53-wild-type tumors. Its central innovation was to use the BH3 mimetic ABT-263 after chemotherapy to selectively eliminate this residual population, while identifying BCL-xL, MCL1, and NOXA expression as determinants of response.
MTT Assay Workflows for Cell Viability Research
2026-09-02
MTT converts cellular reducing activity into a practical purple-formazan readout for proliferation, cytotoxicity, and metabolic studies. This workflow shows how to apply it to dental follicle cell osteogenesis while separating viability effects from differentiation-specific biology.
Trichostatin A (TSA) for Epigenetic Research
2026-09-02
Trichostatin A (TSA) is a reversible histone deacetylase inhibitor that increases histone acetylation and enables controlled studies of chromatin-linked phenotypes. Product data connect TSA with cell-cycle arrest, differentiation, breast cancer growth inhibition, and experimental antitumor activity, while organoid evidence defines important limits for cross-model interpretation.
Dual-Action Inhibitors and p38α Dephosphorylation
2026-09-01
The reference preprint shows that selected kinase inhibitors can do more than block p38α catalytic activity: they can also accelerate WIP1-mediated dephosphorylation by reshaping the kinase activation loop. Structural and biochemical data connect this conformational mechanism to phosphatase access, offering a framework for interpreting p38 MAPK inhibitor experiments and designing more selective kinase-directed interventions.
Dimetridazole Revives Cefotaxime Against MDR E. coli
2026-09-01
The reference study shows that Dimetridazole can potentiate cefotaxime against a multidrug-resistant E. coli strain through changes in membrane permeability, integrity, and fatty acid biosynthesis. Its checkerboard, membrane-imaging, lipid-composition, gene-expression, and Galleria mellonella experiments provide a mechanistic framework for antibiotic combination research, while also highlighting the limits of translating a single-strain result to clinical treatment.
Natural Compounds Targeting SARS-CoV-2 Protease and RBD
2026-08-31
The reference study used virtual screening, molecular docking, and molecular dynamics to evaluate vitamin-derived compounds against both the SARS-CoV-2 main protease and the spike receptor-binding domain. Its central contribution is a dual-target prioritization strategy that identifies overlapping and target-specific candidates for follow-up antiviral therapeutics research, while remaining strictly computational in scope.
463 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page